SER vs SHPH

Serina Therapeutics, Inc. vs Shuttle Pharmaceuticals Holding — Valuation Comparison 2026

SER

Pharmaceutical Preparations
Serina Therapeutics, Inc.
Quality
4.9
out of 10
Value Trap
32
LOW
Price
$1.84
Last close
Models
9/13
Active
VS

SHPH

Pharmaceutical Preparations
Shuttle Pharmaceuticals Holding
Quality
3.6
out of 10
Value Trap
6
SAFE
Price
$0.53
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType SER Fair ValueSER Upside SHPH Fair ValueSHPH Upside
Bayesian DCF Intrinsic $1.12 -39.3% $3.22 +464.6%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.40 -78.2% $0.08 -88.0%
Dynamic NAV Asset-Based $2.49 +35.4% $0.52 -24.7%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for SER vs SHPH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SER vs SHPH — Which Stock Is More Undervalued?

SER scores higher with a 4.9/10 quality rating vs SHPH's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Serina Therapeutics, Inc. (SER) and Shuttle Pharmaceuticals Holding (SHPH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SER currently trades at $1.84 with a QOC of 4.9/10, while SHPH trades at $0.53 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).